This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for BeneFIX® (nonacog alfa) Prescribing Information.  Adverse event reporting information can be found at the bottom of the page.

A guide on how to administer and reconstitute BeneFIX using the R2 device


BeneFIX is administered by intravenous infusion after reconstitution of the lyophilised powder for solution for injection with sterile 0.234% sodium chloride solution.

BeneFIX can be given as on-demand treatment or as prophylaxis.


The R2 device is used for reconstiution of BeneFIX by injection.

We’ve created the ‘BeneFIX R2 infusion mat’ as a support material for your patients. It provides a detailed and visual step-by-step guide on how to use the device. 

You can download the material for your patients by following the link below, or alternatively get in contact with the Pfizer Haemophilia team to request a printed version.

Download the step-by-step guide for your patients

Click here

Explore more

Find out about dosing of BeneFIX for on-demand treatment & prophylaxis

Click here

Find out about flexible dosing & dosing optimisation with BeneFIX​​​​​​​

Click here

  1. BeneFIX (nonacog alfa) Summary of Product Characteristics:
PP-BEN-GBR-0394. March 2021

Contact Pfizer

Speak to a member of the Pfizer haemophilia team.

Click here

Find out about BeneFIX efficacy 

Click here

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020